{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:14:05Z","timestamp":1746321245656},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>While packed red blood cell (PRBC) transfusion therapy is a mainstay in the treatment of certain patients with sickle cell disease (SCD) and the standard of care for preoperative management, there are associated risks. Delayed hemolytic transfusion reaction (DHTR) is a risk of PRBC transfusion occurring 2 to 20 days from transfusion and typically presents with severe pain characteristic of vaso-occlusive crisis, fever, and hemolytic anemia. DHTRs are uncommon, occurring in only 4% to 11% of transfused patients with SCD, but may be catastrophic in nature with progression to multiorgan failure within hours. Here, we describe a case of a 20-year-old female with sickle cell SS disease who developed a severe DHTR 5 days following an elective preoperative PRBC transfusion, and rapidly progressed to multiorgan failure and death. This is the first reported case of a catastrophic DHTR in a patient with SCD without any detectable known or new alloantibodies.<\/jats:p>","DOI":"10.1097\/mph.0000000000001307","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T16:13:19Z","timestamp":1535731999000},"page":"624-626","source":"Crossref","is-referenced-by-count":4,"title":["Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature"],"prefix":"10.1097","volume":"41","author":[{"given":"Sylwia","family":"Jasinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chana L.","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/trf.13379","article-title":"Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series","volume":"56","author":"Nickel","year":"2016","journal-title":"Transfusion"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1213\/ane.0b013e3181930a6e","article-title":"Noninfectious serious hazards of transfusion","volume":"108","author":"Hendrickson","year":"2009","journal-title":"Anesth Analg"},{"issue":"pt 1","key":"R4-20230918","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1542\/peds.111.6.e661","article-title":"Delayed hemolytic transfusion reaction\/hyperhemolysis syndrome in children with sickle cell disease","volume":"111","author":"Talano","year":"2003","journal-title":"Pediatrics"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1537-2995.1997.37497265337.x","article-title":"Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients\u2019 red cells","volume":"37","author":"King","year":"1997","journal-title":"Transfusion"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"R9-20230918","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12288-014-0495-9","article-title":"Fatal delayed haemolytic transfusion reaction and hyperhaemolysis syndrome in a pregnant woman with sickle cell anaemia","volume":"32","author":"Asnawi","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1062. e5","DOI":"10.1016\/j.ajem.2010.01.032","article-title":"Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: a case report and literature review","volume":"28","author":"El-Husseini","year":"2010","journal-title":"Am J Emerg Med"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ajh.24537","article-title":"A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease","volume":"91","author":"Mekontso Dessap","year":"2016","journal-title":"Am J Hematol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ajh.25051","article-title":"Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease","volume":"93","author":"Sagiv","year":"2018","journal-title":"Am J Hematol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tmrv.2009.09.006","article-title":"Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review","volume":"24","author":"Win","year":"2010","journal-title":"Transfus Med Rev"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3324\/haematol.2010.038307","article-title":"Delayed hemolytic transfusion reaction in children with sickle cell disease","volume":"96","author":"de Montalembert","year":"2011","journal-title":"Haematologica"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3324\/haematol.12074","article-title":"Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease","volume":"92","author":"Noizat-Pirenne","year":"2007","journal-title":"Haematologica"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:20:12Z","timestamp":1695010812000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001307","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}